𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential methotrexate/5-fluorouracil in advanced colorectal cancer treatment

✍ Scribed by Evaristo Maiello; Francesco Giotta; Francesco Giuliani; Emanuele Naglieri; Giuseppe Colucci


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
442 KB
Volume
48
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sequential chemotherapy of advanced colo
✍ Solan, Andrew ;Vogl, Steven E. ;Kaplan, Barry H. ;Berenzweig, Marc ;Richard, Jos πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 313 KB

## Abstract Thirty patients with advanced measurable colorectal cancer were randomized to receive either methotrexate (MTX) 200 mg/m^2^ or 40 mg/m^2^, followed in four hours by 5‐fluorouracil (5‐FU) 600 mg/m^2^. Patients receiving the higher dose MTX were given leucovorin rescue 24 hours later. Eig

Preliminary report on the efficacy of se
✍ Alan M. Gewirtz; Ed Cadman πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 2 views

Recent in vitro and animal tumor studies suggest that sequential methotrexate (MTX) and 5-fluorouracil (5-FU) may be much more tumoricidal than either drug when used alone or in conventional combinations. Seventeen evaluable female patients with advanced carcinoma of the breast were treated with MTX

Postsurgical sequential methotrexate, fl
✍ Tokunaga, Yukihiko; Hata, Koichiro; Nishitai, Ryota; Kaganoi, Junichi; Nanbu, Hi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 43 KB

## Background and Objectives: The present study compared the effects of sequential methotrexate and fluorouracil followed by leucovorin rescue (MFL), as an adjuvant chemotherapy versus a combination of tegafur (UFT) and mitomycin C (MMC), on patient survival and recurrence after surgery for colore

Methyl-CCNU, 6-Thioguanine, and 5-fluoro
✍ Aroney, R. S. ;Dalley, D. N. ;Chan, W. K. ;Bell, D. R. ;Levi, J. A. πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 328 KB

## Abstract Consecutive studies were undertaken in advanced colorectal adenocarcinoma, comparing two different schedules of the combination methyl‐CCNU, 6‐thioguanine, and 5‐fluorouracil in 89 patients. The two schedules exhibited similar efficacies, with a combined complete and partial remission r